文献速递流行病学与生物统计组学、生物样本库与精准医学

遗传决定的铁状态与全表型组的关联:一项孟德尔随机化研究

Associations of genetically determined iron status across the phenome: A mendelian randomization study.
PubMed 文献 · PLoS Med · 2019-06-20

研究利用铁状态遗传联盟48,972名欧洲个体的GWAS汇总数据筛选3个铁状态遗传工具,在英国生物银行424,439名欧洲个体中进行孟德尔随机化全表型关联分析。结果显示较高的遗传决定铁状态与缺铁性贫血和高胆固醇血症风险降低相关,与腿部蜂窝织炎和脓肿风险升高相关。

要点

  • 遗传决定血清铁每升高1个标准差,缺铁性贫血OR为0.72(95%CI 0.64-0.81)。
  • 遗传决定血清铁每升高1个标准差,高胆固醇血症OR为0.88(95%CI 0.83-0.93)。
  • 遗传决定血清铁每升高1个标准差,腿部蜂窝织炎和脓肿OR为1.25(95%CI 1.10-1.42)。

核心结论

  • 较高的铁状态可能对高胆固醇血症有保护作用,对皮肤和皮肤结构感染风险有不利作用。
  • 鉴于铁状态可改变且可变,这些发现需进一步研究。

研究设计与样本

  • 利用铁状态遗传联盟19个队列48,972名欧洲个体(55%女性)的GWAS汇总数据识别3个铁状态遗传变异(HFE基因rs1800562和rs1799945,TMPRSS6基因rs855791)。
  • 在英国生物银行424,439名欧洲个体(54%女性,招募时40-69岁,2006至2010年招募,遗传数据链接至1995年4月至2016年3月的医院事件统计)中进行全表型关联研究。
  • 采用两样本汇总数据孟德尔随机化分析,对3个遗传工具分别分析后meta分析合并,使用5%错误发现率阈值校正多重检验,共纳入904个表型。

主要发现

  • 遗传决定血清铁每升高1个标准差,缺铁性贫血OR为0.72(95%CI 0.64-0.81,P=4×10^-8)。
  • 遗传决定血清铁每升高1个标准差,高胆固醇血症OR为0.88(95%CI 0.83-0.93,P=2×10^-5)。
  • 遗传决定血清铁每升高1个标准差,腿部蜂窝织炎和脓肿OR为1.25(95%CI 1.10-1.42,P=6×10^-4)。

关键数值与推荐

  • 3个铁状态遗传工具经多重检验校正后一致显示较高铁状态与贫血相关性状风险降低的因果效应。
  • 3个铁状态遗传工具一致显示较高铁状态与高胆固醇血症风险降低相关。
  • 3个铁状态遗传工具一致显示较高铁状态与皮肤和相关结构感染风险升高相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 可能存在所考虑遗传变异多效性效应导致的偏倚。
  • 医院事件统计数据中诊断可能存在错误分类。
  • 研究仅调查欧洲血统参与者, findings可能不适用于其他族裔群体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Iron is integral to many physiological processes, and variations in its levels, even within the normal range, can have implications for health. The objective of this study was to explore the broad clinical effects of varying iron status. METHODS AND FINDINGS: Genome-wide association study (GWAS) summary data obtained from 48,972 European individuals (55% female) across 19 cohorts in the Genetics of Iron Status Consortium were used to identify 3 genetic variants (rs1800562 and rs1799945 in the hemochromatosis gene [HFE] and rs855791 in the transmembrane protease serine 6 gene [TMPRSS6]) that associate with increased serum iron, ferritin, and transferrin saturation and decreased transferrin levels, thus serving as instruments for systemic iron status. Phenome-wide association study (PheWAS) of these instruments was performed on 424,439 European individuals (54% female) in the UK Biobank who were aged 40-69 years when recruited from 2006 to 2010, with their genetic data linked to Hospital Episode Statistics (HES) from April, 1995 to March, 2016. Two-sample summary data mendelian randomization (MR) analysis was performed to investigate the effect of varying iron status on outcomes across the human phenome. MR-PheWAS analysis for the 3 iron status genetic instruments was performed separately and then pooled by meta-analysis. Correction was made for testing of multiple correlated phenotypes using a 5% false discovery rate (FDR) threshold. Heterogeneity between MR estimates for different instruments was used to indicate possible bias due to effects of the genetic variants through pathways unrelated to iron status. There were 904 distinct phenotypes included in the MR-PheWAS analyses. After correcting for multiple testing, the 3 genetic instruments for systemic iron status demonstrated consistent evidence of a causal effect of higher iron status on decreasing risk of traits related to anemia (iron deficiency anemia: odds ratio [OR] scaled to a standard deviation [SD] increase in genetically determined serum iron levels 0.72, 95% confidence interval [CI] 0.64-0.81, P = 4 × 10-8) and hypercholesterolemia (hypercholesterolemia: OR 0.88, 95% CI 0.83-0.93, P = 2 × 10-5) and increasing risk of traits related to infection of the skin and related structures (cellulitis and abscess of the leg: OR 1.25, 95% CI 1.10-1.42, P = 6 × 10-4). The main limitations of this study relate to possible bias from pleiotropic effects of the considered genetic variants and misclassification of diagnoses in the HES data. Furthermore, this work only investigated participants with European ancestry, and the findings may not be applicable to other ethnic groups. CONCLUSIONS: Our findings offer novel, to our knowledge, insight into previously unreported effects of iron status, highlighting a potential protective effect of higher iron status on hypercholesterolemia and a detrimental role on risk of skin and skin structure infections. Given the modifiable and variable nature of iron status, these findings warrant further investigation.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Gill D, Benyamin B, Moore LSP, et al. Associations of genetically determined iron status across the phenome: A mendelian randomization study. PLoS Med. 2019. PMID: 31220083. doi:10.1371/journal.pmed.1002833

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。